Recent review of COVID-19 management: Diagnosis, treatment and vaccination
The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …
A brief overview of SARS-CoV-2 infection and its management strategies: a recent update
A Das, S Pathak, M Premkumar… - Molecular and Cellular …, 2024 - Springer
The COVID-19 pandemic has become a global health crisis, inflicting substantial morbidity
and mortality worldwide. A diverse range of symptoms, including fever, cough, dyspnea, and …
and mortality worldwide. A diverse range of symptoms, including fever, cough, dyspnea, and …
Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel …
Streptomyces smyrnaeus UKAQ_23, isolated from the mangrove-sediment, collected from
Jubail, Saudi Arabia, exhibited substantial antimicrobial activity against methicillin-resistant …
Jubail, Saudi Arabia, exhibited substantial antimicrobial activity against methicillin-resistant …
[HTML][HTML] Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
Since WHO declared the COVID-19 as a pandemic, 1 2 healthcare systems all over the
world have focused their efforts on limiting the spread of SARS-CoV-2, and despite the …
world have focused their efforts on limiting the spread of SARS-CoV-2, and despite the …
Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation
First emerged in late December 2019, the outbreak of novel severe acute respiratory
syndrome corona virus-2 (SARS-CoV-2) pandemic has instigated public-health emergency …
syndrome corona virus-2 (SARS-CoV-2) pandemic has instigated public-health emergency …
Elucidation of teicoplanin interactions with drug targets related to COVID-19
F Azam - Antibiotics, 2021 - mdpi.com
Teicoplanin is a glycopeptide antibiotic effective against several bacterial infections, has
exhibited promising therapeutic efficiency against COVID-19 in vitro, and the rationale for its …
exhibited promising therapeutic efficiency against COVID-19 in vitro, and the rationale for its …
[HTML][HTML] Prospective mode of action of Ivermectin: SARS-CoV-2
VM Patil, S Verma, N Masand - European Journal of Medicinal Chemistry …, 2022 - Elsevier
The well-known anti-helminthic drug ivermectin (IVM) has been established as an example
of drug repurposing for the management of SARS-CoV-2 infection. Various study has been …
of drug repurposing for the management of SARS-CoV-2 infection. Various study has been …
Microscopic interactions between ivermectin and key human and viral proteins involved in SARS-CoV-2 infection
A Francés-Monerris, C García-Iriepa, I Iriepa… - Physical Chemistry …, 2021 - pubs.rsc.org
The identification of chemical compounds able to bind specific sites of the human/viral
proteins involved in the SARS-CoV-2 infection cycle is a prerequisite to design effective …
proteins involved in the SARS-CoV-2 infection cycle is a prerequisite to design effective …
Elucidation of the inhibitory activity of ivermectin with host nuclear importin α and several SARS-CoV-2 targets
M Bello - Journal of Biomolecular Structure and Dynamics, 2022 - Taylor & Francis
Ivermectin (IVM) is an FDA-approved drug that has shown antiviral activity against a wide
variety of viruses in recent years. IVM inhibits the formation of the importin-α/β1 …
variety of viruses in recent years. IVM inhibits the formation of the importin-α/β1 …
Ebselen suitably interacts with the potential SARS-CoV-2 targets: an in-silico approach
Abstract Ebselen (SPI-1005) is an active selenoorganic compound that can be found
potential inhibitory activity against different types of viral infections such as zika virus …
potential inhibitory activity against different types of viral infections such as zika virus …